EUVIMEDOntdek EUVIMED
Crossref

Antimalarial activity and sensitization of chrysosplenetin against artemisinin‐resistant genotype Plasmodium berghei K173 potentially via dual‐mechanism of maintaining host P‐glycoprotein homeostasis mediated by NF‐κB p52 or PXR / CAR signaling pathways and regulating heme/haemozoin metabolism

Lirong Wang, Hongyan Ji, Shanhong Ni, Jinjing Xu, Yuanyuan Zhang, Xuesong Zhao, Xiuli Wu, Jingxuan Tian, Jing Chen iD

Phytotherapy Research · 2023

DOI: 10.1002/ptr.7789 ↗

At a glance

Journal article in Phytotherapy Research, 2023. Written by Lirong Wang and 8 co-authors. Institution: Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, China. Major MEDLINE topics: Antimalarials, Artemisinins. Cited 9 times so far (Crossref); 44 references. Funded by: National Natural Science Foundation of China, Science and Technology Funds of Kangda College, Nanjing Medical University, Science and Technology Funds of Nanjing Medical University.

SamenvattingSubjectsBibliografische gegevensCiteRelated studies

Abstract (original language)

This study investigated antimalarial efficacy and sensitization of chrysosplenetin against artemisinin‐resistant Plasmodium berghei K173 and potential molecular mechanism. Our data indicated a risk of artemisinin resistance because a higher parasitaemia% and lower inhibition% under artemisinin treatment against resistant parasites than those in the sensitive groups were observed. Two non‐antimalarial components, verapamil and chrysosplentin, being P‐gp inhibitors, possessed a strong efficacy against resistant parasites but it was not the case for Bcrp inhibitor novobiocin. Artemisinin‐chrysosplenetin combination improved artemisinin susceptibility of resistant P. berghei . Artemisinin activated intestinal P‐gp and Abcb1/Abcg2 expressions and suppressed Bcrp whereas chrysosplenetin reversed them. Resistant parasite infection led to a decreased haemozoin in organs or an increased heme in peripheral bloods compared with the sensitives; however, that in Abcb1‐deficient knockout (KO)‐resistant mice reversely got increased or decreased versus wild type (WT)‐resistant animals. Chrysosplenetin as well as rifampin (nuclear receptor agonist) increased the transcription levels of PXR/CAR while showed a versatile regulation on hepatic and enternal PXR/CAR in WT‐ or KO‐sensitive or ‐resistant parasites. Oppositely, hepatic and enteric NF‐κB p52 mRNA decreased conformably in WT but increased in KO‐resistant mice. NF‐κB pathway potentially involved in the mechanism of chrysosplenetin on inhibiting P‐gp expressions while PXR/CAR play a more complicated role in this mechanism.

Subjects

MeSH terms (MEDLINE)

AntimalarialsArtemisininsMiceAnimalsPlasmodium bergheiNF-kappa B p52 SubunitATP Binding Cassette Transporter, Subfamily G, Member 2Neoplasm ProteinsSignal TransductionATP Binding Cassette Transporter, Subfamily BHomeostasisHemeHemeproteinsFlavonoids

Author keywords

P-glycoproteinPXR/CAR and NF-κB p52 signal pathwaysPlasmodium berghei K173artemisinin resistancechrysosplenetinheme/haemozoin metabolism

Substances

AntimalarialsNF-kappa B p52 SubunitATP Binding Cassette Transporter, Subfamily G, Member 2Neoplasm ProteinsArtemisininsATP Binding Cassette Transporter, Subfamily BHemehemozoinHemeproteinschrysosplenetin

Authors and institutions

  • Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, China.
  • Institute of Clinical Pharmacology, General Hospital of Ningxia Medical University, Yinchuan, China.
  • Department of Public Health and Preventive Medicine, Kangda College of Nanjing Medical University, Lianyungang, China.
  • College of Pharmacy, Ningxia Medical University, Yinchuan, China.
  • Jiangsu Key Laboratory of Zoonosis, Yangzhou University, Yangzhou, China.
  • Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zonoses, Yangzhou, China.

ORCID profiles: Jing Chen

Funding

  • National Natural Science Foundation of China
  • Science and Technology Funds of Kangda College, Nanjing Medical University
  • Science and Technology Funds of Nanjing Medical University

Cite

APA

Wang, L., Ji, H., Ni, S., Xu, J., Zhang, Y., Zhao, X., Wu, X., Tian, J., & Chen, J. (2023). Antimalarial activity and sensitization of chrysosplenetin against artemisinin‐resistant genotype Plasmodium berghei K173 potentially via dual‐mechanism of maintaining host P‐glycoprotein homeostasis mediated by NF‐κB p52 or PXR / CAR signaling pathways and regulating heme/haemozoin metabolism. Phytotherapy Research. https://doi.org/10.1002/ptr.7789

Vancouver

Wang L, Ji H, Ni S, Xu J, Zhang Y, Zhao X, et al. Antimalarial activity and sensitization of chrysosplenetin against artemisinin‐resistant genotype Plasmodium berghei K173 potentially via dual‐mechanism of maintaining host P‐glycoprotein homeostasis mediated by NF‐κB p52 or PXR / CAR signaling pathways and regulating heme/haemozoin metabolism. Phytotherapy Research. 2023. doi:10.1002/ptr.7789

BibTeX
@article{Wang2023,
  author = {Wang, Lirong and Ji, Hongyan and Ni, Shanhong and Xu, Jinjing and Zhang, Yuanyuan and Zhao, Xuesong and Wu, Xiuli and Tian, Jingxuan and Chen, Jing},
  title = {Antimalarial activity and sensitization of chrysosplenetin against artemisinin‐resistant genotype Plasmodium berghei K173 potentially via dual‐mechanism of maintaining host P‐glycoprotein homeostasis mediated by NF‐κB p52 or PXR / CAR signaling pathways and regulating heme/haemozoin metabolism},
  journal = {Phytotherapy Research},
  year = {2023},
  doi = {10.1002/ptr.7789}
}
Start for free →